Thorough QT/QTc Study to Evaluate the Effects of Ecopipam (EBS-101) on Cardiac Repolarization
Clinical trial NCT05841160 · COMPLETED
Trial details
- NCT number
- NCT05841160
- Sponsor
- Emalex Biosciences Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-15
- Primary completion
- 2023-05-07
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.